Abstract
A variety of different applications render terpenes and terpenoids attractive research targets. A promising but so far insufficiently explored family of terpenoids are the fusicoccanes that comprise a characteristic 5-8-5 fused tricyclic ring system. Besides herbicidal effects, these compounds also show apoptotic and anti-tumour effects on mammalian cells. The access to fusicoccanes from natural sources is scarce. Recently, we introduced a metabolically engineered Saccharomyces cerevisiae strain to enable the heterologous fermentation of the shared fusicoccane-diterpenoid precursor, fusicocca-2,10(14)-diene. Here, we show experiments towards the identification of bottlenecks in this process. The suppression of biosynthetic by-products via medium optimisation was found to be an important aspect. In addition, the fermentation process seems to be improved under oxygen limitation conditions. Under fed-batch conditions, the fermentation yield was reproducibly increased to approximately 20 mg/L. Furthermore, the impact of the properties of the terpene synthase on the fermentation yield is discussed, and the preliminary studies on the engineering of this key enzyme are presented. © 2014 © 2014 The Author(s). Published by Taylor & Francis.
Author supplied keywords
Cite
CITATION STYLE
Arens, J., Bergs, D., Mewes, M., Merz, J., Schembecker, G., & Schulz, F. (2014). Heterologous fermentation of a diterpene from Alternaria brassisicola. Mycology, 5(3), 207–219. https://doi.org/10.1080/21501203.2014.917735
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.